Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11

Completed · Phase 4

Conditions studied: Cocaine-Related Disorders, Substance-Related Disorders

In brief

The purpose of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.

Key facts

Study ID

NCT00015301

Run by

National Institute on Drug Abuse (NIDA)

People needed

0

Starts

2003-12-01

Expected to finish

2005-08-01

Last updated by the study team

2017-02-24

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Healthy normals

You may not qualify if…

• History of head trauma or loss of consciousness. Significant medical history. History of seizures.

Where it is running

• New York MDRU — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.